Mitochondrion-targeted RNA therapies as a potential treatment strategy for mitochondrial diseases

Mitochondrial diseases are one of the largest groups of neurological genetic disorders. Despite continuous efforts of the scientific community, no cure has been developed, and most treatment strategies rely on managing the symptoms. After the success of coronavirus disease 2019 (COVID-19) mRNA vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Chernega, Timofei, Choi, Jaehyoung, Salmena, Leonardo, Andreazza, Ana Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664406/
https://www.ncbi.nlm.nih.gov/pubmed/36420220
http://dx.doi.org/10.1016/j.omtn.2022.10.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664406/
https://www.ncbi.nlm.nih.gov/pubmed/36420220
http://dx.doi.org/10.1016/j.omtn.2022.10.012

Ejemplares similares